Class 424/246.1 - Bacillus

Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the bacterium is of the genus Bacillus.
No. of patents: 86
Last issue date: 01/31/2012

«First «Previous 1 2 3 Next»Last»

Number	Title	Issue Date
6723326	Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical ...	04/20/2004
6713063	Broad-spectrum δ-endotoxins Disclosed are novel synthetically-modified B. thuringiensis chimeric crystal proteins having improved insecticidal activity and broader insect host range against coleopteran, dipteran and lepidopteran insects. Also disclosed are the nucleic acid segments enco...	03/30/2004
6645515	Bacteriostatic composition for salmonellae Provided is a bacteriostatic composition for salmonellae containing, as the active ingredient, a fermented broth obtained by effecting fermentation with the use of a lactic acid bacteriium belonging to the genus Leuconostoc, Streptococcus or Streptobacter...	11/11/2003
6645497	Polynucleotide compositions encoding broad-spectrum δ endotoxins Disclosed, are novel synthetically-modified B. thuringiensis chimeric crystal proteins having improved insecticidal activity against coleopteran, dipteran and lepidopteran insects. Also disclosed are the nucleic acid segments encoding these novel peptides...	11/11/2003
6645506	Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical app...	11/11/2003
6592872	Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein The present invention provides a vaccine for inducing an immune response in mammal to a specific antigen, where the vaccine comprises a unit dose of a binary, cytotoxic T lymphocyte vaccine comprising an anthrax protective antigen and a full length protei...	07/15/2003
6541448	Polypeptide compositions toxic to anthonomus insects, and methods of use A novel gene encoding a Coleopteran inhibitory Bacillus thuringiensis insecticidal crystal protein is disclosed. The protein, tIC851, is insecticidally active and provides plant protection from at least cotton boll weevil, Anthomomus grandis, when applied...	04/01/2003
6506389	ADHERENCE FACTORS OF NON PATHOGENIC MICROORGANISMS AND APPLICATIONS THEREOF FOR SCREENING MICROORGANISMS FOR SPECIFIC PROBIOTIC PROPERTIES; NOVEL PHARMACEUTICAL COMPOSITIONS AND FOOD ADDITIVES COMPRISING SUCH MICROORGANISMS AND ADHERENCE FACTORS A protein obtainable from a non pathgenic microorgansim, said protein having mucosa binding promoting activity and a molecular weight of 20-40 kD is disclosed. Application of such a protein or a peptide derived therefrom in a method of screening non patho...	01/14/2003
6486132	Immunomodulator, immunomodulator food and immunomodulator feed To provide an immunomodulator in which DNA can be administered orally or percutaneously, not through injection, or can be taken daily like a food, or an immunomodulator food or feed. DNA derived from cells of procaryotes such as Bacillus subtilis, lactic ...	11/26/2002
6482412	Polypeptide having human HIV inhibitory activity, a gene encoding the polypeptide, a method to produce the polypeptide A novel compound, which is effective for treatment of AIDS and has inhibitory activity on human immunodeficiency viruses (HIV), was examined. The K97-0003 peptide, which has anti-HIV activity caused by inhibition of syncytium formation by fusion of envelo...	11/19/2002
6451338	Liposomes containing particulate materials A method is provided for the formation of liposomes of 0.1 μm to 50 μm in diameter having unilamella or multilamella structure and containing water insoluble or undissolved particulate materials comprising (a) forming liposomes and removing substantiall...	09/17/2002
6387665	Method of making a vaccine for anthrax A method of making a vaccine for anthracis that inolves a bacterial expression system and production and use of protective antigen (PA) against Bacillus anthracis. The PA immunogen is useful in a vaccine against human anthrax. The PA can be produced by an...	05/14/2002
6322809	Liposomes containing particulate materials A method is provided for the formation of liposomes of 0.1 μm to 50 μm in diameter having unilamella or multilamella structure and containing water insoluble or undissolved particulate materials comprising (a) forming liposomes and removing substantiall...	11/27/2001
6316006	Asporogenic B anthracis expression system This invention relates to a bacterial expression system for production of protective antigen (PA) against bacillus anthracis. Recombinant asporogenic B. anthracits that are derived from ƊSterne-1(pPA102) and show inability to bind the dye when grown on C...	11/13/2001
6270777	Conserved metalloprotease epitopes The present invention provides immunogenic compositions comprising peptides derived from the amino acid sequence of P. aeruginosa for protecting susceptible hosts against diseases caused by bacterial pathogens which secrete a zinc metalloprotease....	08/07/2001
6221649	Chimeric bacillus thuringiensis-endotoxins and host cells expressing same Disclosed are novel synthetically-modified B. thuringiensis chimeric crystal proteins having improved insecticidal activity against coleopteran, dipteran and lepidopteran insects. Also disclosed are the nucleic acid segments encoding these novel peptides....	04/24/2001
6214364	Materials and methods for pest control The subject invention concerns methods and compositions for the selective control of pest. The method involves the administration of an enzyme that disrupts an ecdysteroid metabolic pathway wherein said ecdysteroid pathway exists in said pest but not in m...	04/10/2001
6190887	Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein Disclosed are methods, nucleic acids, and cells for expressing an exogenous gene in a mammalian cell, involving introducing into the cell a non-mammalian DNA virus (e.g., a baculovirus) having an altered coat protein, the genome of which virus carries an ...	02/20/2001
6183993	Complement-resistant non-mammalian DNA viruses and uses thereof Disclosed are methods, nucleic acids, and cells for expressing an exogenous gene in a mammalian cell, involving (i) introducing into the cell a complement-resistant non-mammalian DNA virus (e.g., a baculovirus), optionally having an altered coat protein, ...	02/06/2001
6162433	Non antibiotic selectable markers for live vaccines The invention relates to DNA constructs encoding a safe, selectable marker, other than an antibiotic resistance marker, vectors and/or cells including said constructs; and vaccines based on said constructs for use in animals and particularly humans. The s...	12/19/2000
6156320	Fermented milk nutraceuticals Methods for treating or preventing diseases or conditions, which are associated with or caused or contributed to by an opportunistic or pathogenic microorganism in a subject, comprising administering to the subject an effective amount of a culture of lact...	12/05/2000
6150156	Bacillus thuringiensis isolates active against sucking insects The subject invention concerns novel Bacillus thuringiensis strains containing parasporal proteins with pesticidal properties against whitefly, aphid, jassid, and possibly other sucking insects of agronomic importance, and peptide sequences to these prote...	11/21/2000
6110464	Broad-spectrum δ-endotoxins Disclosed are novel synthetically-modified B. thuringiensis chimeric crystal proteins having improved insecticidal activity against coleopteran, dipteran and lepidopteran insects. Also disclosed are the nucleic acid segments encoding these novel peptides....	08/29/2000
6099848	Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use Listeria monocytogenes is an intracellular bacterial pathogen that elicits a strong cellular immune response following infection and therefore has potential use as a vaccine vector. However, while infections by L. monocytogenes are fairly rare and can rea...	08/08/2000
6096310	Oral immunotherapy of bacterial overgrowth The object of the present invention is the oral administration of animal immunoglobulins for the treatment of gastrointestinal disorders caused by bacterial and/or yeast overgrowth. Immunoglobulins derived from the blood, plasma or serum of animals, such ...	08/01/2000
6051552	Lactobacillus therapies The present invention is directed towards isolated lactobacillus biosurfactants and the process for producing same. The present invention is also directed to methods for preventing urogenital infection in mammals using the isolated lactobacillus biosurfac...	04/18/2000
6027735	Products and processes for gastric cascade and gastrointestinal disorder treatment with same The present invention provides a method and products for establishing nutrient recognition and improving nutrient utilization and growth in a human or an animal by immunologically stimulating digestion or a gastric cascade within the gastrointestinal trac...	02/22/2000
6019985	Immunostimulation methods for providing disease protection in poultry Methods are provided for improved immunization against coccidiosis and other bacterial, viral, or parasitic diseases in poultry. One method includes administering a solution of Propionibacterium acnes suspended in normal saline to a chick at age day one, ...	02/01/2000
6017534	Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity Disclosed are novel synthetically-modified B. thuringiensis chimeric crystal proteins having improved insecticidal activity against coleopteran, dipteran and lepidopteran insects. Also disclosed are the nucleic acid segments encoding these novel peptides....	01/25/2000
5929109	Enhancing and stabilizing agent of the activity of Bifidus factor The present invention relates to an agent for enhancing and stabilizing the activity of Bifidus factor, containing at least one member selected from the group consisting of ascorbic acid, hyposulfurous acid and acetic anhydride as the effective ingredient...	07/27/1999
5858367	Methods for screening for antimicrobials utilizing AarC and compositions thereof The present invention provides an oligonucleotide (aarC) which encodes a novel bacterial polypeptide (AarC) that is essential for the viability of bacteria. The invention provides recombinant expression vectors comprising the nucleotide sequence encoding ...	01/12/1999
5840312	Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein A recombinant strain of B. anthracis is characterized in that it can induce the production of protective antibodies against virulent strains of B. anthracis in a human or animal host, and characterized also by the mutation of the pX01 plasmid of at least ...	11/24/1998
5800821	Bacterial spores as a heat stable vaccine delivery system A method of stimulating a vertebrate animal to produce an immune response to at least one antigen is described. The method includes genetically engineering a bacterial cell with DNA encoding at least one antigen and inducing the bacterial cell to sporulat...	09/01/1998
5763226	Bacillus cereus enterotoxin and method of use The characterization of the protein structure of an enterotoxin to Bacillus cereus, designated hemolysin BL, is described herein. A high-yield purification scheme which allows quantitative characterization of the hemolysin BL activity is also described....	06/09/1998
5744134	Immunoglobulin and fiber-containing composition for human gastrointestinal health A composition for restoring and maintaining gastrointestinal health comprises 40-60% by weight of an immunoglobulin composition comprising concentrated immunologically active immunoglobulins and 40-60% by weight of soluble dietary fiber selected from inul...	04/28/1998
5741494	Immunopotentiative and infection-protective agent containing bacillus and egg white Synergistic compositions of egg white and Bacillus subtilis, Bacillus celleus, Lactobacillus lactis, Lactobacillus casei, Bifidobacterium bifidum or Clostridium and optionally also containing garlic for treating and preventing infections and other uses ar...	04/21/1998
5733544	Nematicidal bacillus strain and metabolite and methods of use thereof The present invention relates to a newly discovered Bacillus sp. strain which exhibits pesticidal activity. The supernatant of cultures of this novel isolate are also effective pesticidal agents. Also provided are methods of using the novel strain or supe...	03/31/1998
5728385	Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae A method of immunization, and compositions therefor, are provided for substantially preventing or reducing the symptoms of at least one infectious disease and at least one chronic immune mediated disorder. An immunogenic challenge which supplements the no...	03/17/1998
5725861	Products and processes for gastric cascade and gastrointestinal disorder treatment with same The present invention provides a method and products for establishing nutrient recognition and improving nutrient utilization and growth in a human or an animal by immunologically stimulating digestion or a gastric cascade within the gastrointestinal trac...	03/10/1998
5573766	Bacillus thuringiensis strains producing insecticidally active toxins Novel strains of the insecticidal microorganism Bacillus thuringiensis are described. These contain novel genes, and in particular a gene coding for a novel insecticidal endotoxin, 81 kiloDaltons in length, toxic to both Lepidoptera and Coleoptera. The no...	11/12/1996

«First «Previous 1 2 3 Next»Last»

PatentStorm

Bizarre Patents

PatentStorm News

Class 424/246.1 - Bacillus